Christ, I think you could make a strong argument that Travelan, if the active ingredients are indeed effective as a Shigella vaccine, is worth $200-$300 million by itself. I posted on here a day or two ago a company that one of the Big Pharmas purchased for $215 million two years ago for a promising Phase 1 Shigella vaccine. That's literally all the company had.
* GSK was the buyer
Big Pharma Partnership, page-5
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $1.158K | 11.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9352 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 251204 | 4 |
View Market Depth
| Last trade - 10.48am 27/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |